nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CYP2D6—Lomustine—brain cancer	0.0881	0.174	CbGbCtD
Pimozide—CYP1A2—Carmustine—brain cancer	0.0871	0.173	CbGbCtD
Pimozide—CYP2D6—Hydroxyurea—brain cancer	0.0667	0.132	CbGbCtD
Pimozide—CYP3A4—Temozolomide—brain cancer	0.0659	0.13	CbGbCtD
Pimozide—CYP3A4—Lomustine—brain cancer	0.056	0.111	CbGbCtD
Pimozide—CYP2E1—Etoposide—brain cancer	0.0447	0.0884	CbGbCtD
Pimozide—CYP3A5—Etoposide—brain cancer	0.0347	0.0687	CbGbCtD
Pimozide—CYP1A2—Etoposide—brain cancer	0.0258	0.0511	CbGbCtD
Pimozide—ABCB1—Etoposide—brain cancer	0.0226	0.0447	CbGbCtD
Pimozide—CYP3A4—Etoposide—brain cancer	0.0135	0.0268	CbGbCtD
Pimozide—DRD3—telencephalic ventricle—brain cancer	0.00763	0.0389	CbGeAlD
Pimozide—HTR2A—choroid plexus—brain cancer	0.00726	0.0371	CbGeAlD
Pimozide—CALM1—trigeminal nerve—brain cancer	0.00603	0.0308	CbGeAlD
Pimozide—HRH1—nose—brain cancer	0.0056	0.0286	CbGeAlD
Pimozide—Tonic-clonic seizures—Carmustine—brain cancer	0.00551	0.0356	CcSEcCtD
Pimozide—OPRM1—telencephalic ventricle—brain cancer	0.00484	0.0247	CbGeAlD
Pimozide—HTR6—ganglion—brain cancer	0.00457	0.0233	CbGeAlD
Pimozide—CALM1—cranial nerve—brain cancer	0.0043	0.0219	CbGeAlD
Pimozide—CALM2—pons—brain cancer	0.00427	0.0218	CbGeAlD
Pimozide—CALM1—pons—brain cancer	0.00425	0.0217	CbGeAlD
Pimozide—Abnormal behaviour—Temozolomide—brain cancer	0.00385	0.0248	CcSEcCtD
Pimozide—HTR2A—trigeminal nerve—brain cancer	0.00367	0.0187	CbGeAlD
Pimozide—HTR2A—cerebellar cortex—brain cancer	0.00366	0.0187	CbGeAlD
Pimozide—HTR1A—telencephalic ventricle—brain cancer	0.00357	0.0182	CbGeAlD
Pimozide—HTR2A—vein—brain cancer	0.00332	0.0169	CbGeAlD
Pimozide—DRD2—telencephalic ventricle—brain cancer	0.00323	0.0165	CbGeAlD
Pimozide—Grand mal convulsion—Carmustine—brain cancer	0.00312	0.0201	CcSEcCtD
Pimozide—CALM2—pineal body—brain cancer	0.00304	0.0155	CbGeAlD
Pimozide—CALM1—pineal body—brain cancer	0.00303	0.0155	CbGeAlD
Pimozide—OPRM1—ganglion—brain cancer	0.00301	0.0154	CbGeAlD
Pimozide—Faecal incontinence—Carmustine—brain cancer	0.00294	0.019	CcSEcCtD
Pimozide—Visual disturbance—Lomustine—brain cancer	0.00286	0.0185	CcSEcCtD
Pimozide—Faecal incontinence—Temozolomide—brain cancer	0.00284	0.0183	CcSEcCtD
Pimozide—Amenorrhoea—Procarbazine—brain cancer	0.0027	0.0174	CcSEcCtD
Pimozide—HTR2A—cranial nerve—brain cancer	0.00262	0.0134	CbGeAlD
Pimozide—HTR2A—pons—brain cancer	0.00259	0.0132	CbGeAlD
Pimozide—CACNA1G—telencephalon—brain cancer	0.00257	0.0131	CbGeAlD
Pimozide—Nocturia—Procarbazine—brain cancer	0.00256	0.0165	CcSEcCtD
Pimozide—Pancytopenia—Lomustine—brain cancer	0.00223	0.0144	CcSEcCtD
Pimozide—HTR1A—ganglion—brain cancer	0.00222	0.0113	CbGeAlD
Pimozide—CALM2—ganglion—brain cancer	0.00218	0.0111	CbGeAlD
Pimozide—CALM1—ganglion—brain cancer	0.00217	0.0111	CbGeAlD
Pimozide—HTR2A—telencephalic ventricle—brain cancer	0.00213	0.0109	CbGeAlD
Pimozide—Gynaecomastia—Procarbazine—brain cancer	0.00212	0.0137	CcSEcCtD
Pimozide—Amenorrhoea—Hydroxyurea—brain cancer	0.00209	0.0135	CcSEcCtD
Pimozide—DRD2—ganglion—brain cancer	0.00201	0.0102	CbGeAlD
Pimozide—Haemolytic anaemia—Procarbazine—brain cancer	0.00191	0.0123	CcSEcCtD
Pimozide—Extrapyramidal disorder—Temozolomide—brain cancer	0.0019	0.0123	CcSEcCtD
Pimozide—CALM2—endothelium—brain cancer	0.00188	0.00961	CbGeAlD
Pimozide—CALM1—endothelium—brain cancer	0.00188	0.00956	CbGeAlD
Pimozide—HTR2A—pineal body—brain cancer	0.00185	0.00942	CbGeAlD
Pimozide—Visual impairment—Lomustine—brain cancer	0.00181	0.0117	CcSEcCtD
Pimozide—HTR6—telencephalon—brain cancer	0.00176	0.00899	CbGeAlD
Pimozide—CALM2—blood vessel—brain cancer	0.00174	0.00886	CbGeAlD
Pimozide—Endocrine disorder—Temozolomide—brain cancer	0.00173	0.0112	CcSEcCtD
Pimozide—CALM1—blood vessel—brain cancer	0.00173	0.00882	CbGeAlD
Pimozide—Speech disorder—Carmustine—brain cancer	0.00173	0.0111	CcSEcCtD
Pimozide—HTR1A—hindbrain—brain cancer	0.00169	0.0086	CbGeAlD
Pimozide—Speech disorder—Temozolomide—brain cancer	0.00167	0.0108	CcSEcCtD
Pimozide—CALM2—hindbrain—brain cancer	0.00166	0.00845	CbGeAlD
Pimozide—CALM1—hindbrain—brain cancer	0.00165	0.00841	CbGeAlD
Pimozide—Amenorrhoea—Temozolomide—brain cancer	0.00163	0.0105	CcSEcCtD
Pimozide—CACNA1G—head—brain cancer	0.0016	0.00816	CbGeAlD
Pimozide—DRD2—hindbrain—brain cancer	0.00152	0.00777	CbGeAlD
Pimozide—Dysphagia—Procarbazine—brain cancer	0.00149	0.00961	CcSEcCtD
Pimozide—Eosinophilia—Procarbazine—brain cancer	0.00147	0.00951	CcSEcCtD
Pimozide—Leukopenia—Lomustine—brain cancer	0.00146	0.00944	CcSEcCtD
Pimozide—CACNA1G—central nervous system—brain cancer	0.00146	0.00745	CbGeAlD
Pimozide—CACNA1G—cerebellum—brain cancer	0.00143	0.00728	CbGeAlD
Pimozide—Pancytopenia—Procarbazine—brain cancer	0.00141	0.00912	CcSEcCtD
Pimozide—Pollakiuria—Procarbazine—brain cancer	0.00137	0.00887	CcSEcCtD
Pimozide—Aplastic anaemia—Temozolomide—brain cancer	0.00135	0.00869	CcSEcCtD
Pimozide—Gynaecomastia—Carmustine—brain cancer	0.00133	0.00857	CcSEcCtD
Pimozide—Drowsiness—Procarbazine—brain cancer	0.00133	0.00856	CcSEcCtD
Pimozide—HTR2A—ganglion—brain cancer	0.00132	0.00676	CbGeAlD
Pimozide—OPRM1—brainstem—brain cancer	0.00131	0.00667	CbGeAlD
Pimozide—Sweating—Procarbazine—brain cancer	0.00127	0.00821	CcSEcCtD
Pimozide—Anorexia—Lomustine—brain cancer	0.00127	0.0082	CcSEcCtD
Pimozide—Breast disorder—Hydroxyurea—brain cancer	0.0012	0.00777	CcSEcCtD
Pimozide—OPRM1—telencephalon—brain cancer	0.00116	0.00592	CbGeAlD
Pimozide—CACNA1G—brain—brain cancer	0.00116	0.00592	CbGeAlD
Pimozide—Decreased appetite—Lomustine—brain cancer	0.00116	0.00748	CcSEcCtD
Pimozide—HTR2A—endothelium—brain cancer	0.00114	0.00583	CbGeAlD
Pimozide—DRD3—head—brain cancer	0.00114	0.00582	CbGeAlD
Pimozide—CYP3A7—endocrine gland—brain cancer	0.00113	0.00576	CbGeAlD
Pimozide—HTR6—head—brain cancer	0.0011	0.0056	CbGeAlD
Pimozide—Pancytopenia—Hydroxyurea—brain cancer	0.00109	0.00706	CcSEcCtD
Pimozide—Hyponatraemia—Carmustine—brain cancer	0.00108	0.00698	CcSEcCtD
Pimozide—CALM3—telencephalon—brain cancer	0.00107	0.00547	CbGeAlD
Pimozide—CHRM2—telencephalon—brain cancer	0.00106	0.00539	CbGeAlD
Pimozide—HTR2A—blood vessel—brain cancer	0.00105	0.00537	CbGeAlD
Pimozide—Weight increased—Hydroxyurea—brain cancer	0.00105	0.00677	CcSEcCtD
Pimozide—DRD3—central nervous system—brain cancer	0.00104	0.00531	CbGeAlD
Pimozide—Drowsiness—Hydroxyurea—brain cancer	0.00103	0.00663	CcSEcCtD
Pimozide—OPRK1—head—brain cancer	0.00102	0.00518	CbGeAlD
Pimozide—HTR2A—hindbrain—brain cancer	0.001	0.00512	CbGeAlD
Pimozide—HTR6—central nervous system—brain cancer	0.001	0.00511	CbGeAlD
Pimozide—Tremor—Procarbazine—brain cancer	0.000971	0.00627	CcSEcCtD
Pimozide—HTR1A—brainstem—brain cancer	0.000966	0.00493	CbGeAlD
Pimozide—Anaemia—Procarbazine—brain cancer	0.000958	0.00619	CcSEcCtD
Pimozide—CALM2—brainstem—brain cancer	0.00095	0.00484	CbGeAlD
Pimozide—CALM1—brainstem—brain cancer	0.000945	0.00482	CbGeAlD
Pimozide—Breast disorder—Temozolomide—brain cancer	0.000941	0.00607	CcSEcCtD
Pimozide—Dysphagia—Carmustine—brain cancer	0.000931	0.00601	CcSEcCtD
Pimozide—Syncope—Procarbazine—brain cancer	0.00093	0.006	CcSEcCtD
Pimozide—Leukopenia—Procarbazine—brain cancer	0.000928	0.00599	CcSEcCtD
Pimozide—OPRK1—central nervous system—brain cancer	0.000928	0.00473	CbGeAlD
Pimozide—CYP2D6—hindbrain—brain cancer	0.000915	0.00467	CbGeAlD
Pimozide—Loss of consciousness—Procarbazine—brain cancer	0.000911	0.00588	CcSEcCtD
Pimozide—OPRK1—cerebellum—brain cancer	0.000907	0.00463	CbGeAlD
Pimozide—Dysphagia—Temozolomide—brain cancer	0.0009	0.00581	CcSEcCtD
Pimozide—Convulsion—Procarbazine—brain cancer	0.000898	0.0058	CcSEcCtD
Pimozide—Hypertension—Procarbazine—brain cancer	0.000895	0.00578	CcSEcCtD
Pimozide—Pancytopenia—Carmustine—brain cancer	0.000884	0.00571	CcSEcCtD
Pimozide—Myalgia—Procarbazine—brain cancer	0.000883	0.0057	CcSEcCtD
Pimozide—CALM3—pituitary gland—brain cancer	0.000874	0.00446	CbGeAlD
Pimozide—DRD2—brainstem—brain cancer	0.000873	0.00445	CbGeAlD
Pimozide—Dry mouth—Procarbazine—brain cancer	0.000863	0.00557	CcSEcCtD
Pimozide—HTR1A—telencephalon—brain cancer	0.000857	0.00437	CbGeAlD
Pimozide—Pancytopenia—Temozolomide—brain cancer	0.000854	0.00552	CcSEcCtD
Pimozide—Vomiting—Lomustine—brain cancer	0.000847	0.00547	CcSEcCtD
Pimozide—CALM3—medulla oblongata—brain cancer	0.000843	0.0043	CbGeAlD
Pimozide—CALM2—telencephalon—brain cancer	0.000843	0.0043	CbGeAlD
Pimozide—CALM1—telencephalon—brain cancer	0.000839	0.00428	CbGeAlD
Pimozide—OPRM1—midbrain—brain cancer	0.000834	0.00425	CbGeAlD
Pimozide—Shock—Procarbazine—brain cancer	0.000833	0.00537	CcSEcCtD
Pimozide—Pollakiuria—Temozolomide—brain cancer	0.000831	0.00536	CcSEcCtD
Pimozide—Erectile dysfunction—Temozolomide—brain cancer	0.000829	0.00535	CcSEcCtD
Pimozide—Depression—Carmustine—brain cancer	0.000828	0.00534	CcSEcCtD
Pimozide—DRD3—brain—brain cancer	0.000826	0.00422	CbGeAlD
Pimozide—Tachycardia—Procarbazine—brain cancer	0.000826	0.00533	CcSEcCtD
Pimozide—Weight increased—Temozolomide—brain cancer	0.000819	0.00529	CcSEcCtD
Pimozide—Hyperhidrosis—Procarbazine—brain cancer	0.000818	0.00528	CcSEcCtD
Pimozide—Weight decreased—Temozolomide—brain cancer	0.000814	0.00525	CcSEcCtD
Pimozide—OPRM1—spinal cord—brain cancer	0.000814	0.00415	CbGeAlD
Pimozide—Anorexia—Procarbazine—brain cancer	0.000807	0.00521	CcSEcCtD
Pimozide—Depression—Temozolomide—brain cancer	0.0008	0.00516	CcSEcCtD
Pimozide—HTR6—brain—brain cancer	0.000796	0.00406	CbGeAlD
Pimozide—Nausea—Lomustine—brain cancer	0.000792	0.00511	CcSEcCtD
Pimozide—Hypotension—Procarbazine—brain cancer	0.000791	0.0051	CcSEcCtD
Pimozide—DRD2—telencephalon—brain cancer	0.000775	0.00395	CbGeAlD
Pimozide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000771	0.00498	CcSEcCtD
Pimozide—CALM3—midbrain—brain cancer	0.000771	0.00393	CbGeAlD
Pimozide—Insomnia—Procarbazine—brain cancer	0.000765	0.00494	CcSEcCtD
Pimozide—KCNH2—telencephalon—brain cancer	0.000763	0.00389	CbGeAlD
Pimozide—Somnolence—Procarbazine—brain cancer	0.000752	0.00486	CcSEcCtD
Pimozide—CALM3—spinal cord—brain cancer	0.000752	0.00384	CbGeAlD
Pimozide—Cramp muscle—Etoposide—brain cancer	0.00075	0.00484	CcSEcCtD
Pimozide—Anaemia—Hydroxyurea—brain cancer	0.000742	0.00479	CcSEcCtD
Pimozide—OPRK1—brain—brain cancer	0.000737	0.00376	CbGeAlD
Pimozide—Decreased appetite—Procarbazine—brain cancer	0.000736	0.00475	CcSEcCtD
Pimozide—OPRM1—endocrine gland—brain cancer	0.000732	0.00374	CbGeAlD
Pimozide—Connective tissue disorder—Carmustine—brain cancer	0.000732	0.00473	CcSEcCtD
Pimozide—Constipation—Procarbazine—brain cancer	0.000724	0.00467	CcSEcCtD
Pimozide—OPRM1—head—brain cancer	0.000723	0.00369	CbGeAlD
Pimozide—Dysphagia—Etoposide—brain cancer	0.00072	0.00465	CcSEcCtD
Pimozide—Leukopenia—Hydroxyurea—brain cancer	0.000718	0.00464	CcSEcCtD
Pimozide—Visual impairment—Carmustine—brain cancer	0.000718	0.00464	CcSEcCtD
Pimozide—Connective tissue disorder—Temozolomide—brain cancer	0.000708	0.00457	CcSEcCtD
Pimozide—CALM2—gonad—brain cancer	0.000703	0.00359	CbGeAlD
Pimozide—CALM1—gonad—brain cancer	0.0007	0.00357	CbGeAlD
Pimozide—Eye disorder—Carmustine—brain cancer	0.000696	0.0045	CcSEcCtD
Pimozide—Convulsion—Hydroxyurea—brain cancer	0.000695	0.00449	CcSEcCtD
Pimozide—Visual impairment—Temozolomide—brain cancer	0.000694	0.00448	CcSEcCtD
Pimozide—ABCB1—blood vessel—brain cancer	0.00069	0.00352	CbGeAlD
Pimozide—CALM2—pituitary gland—brain cancer	0.000686	0.0035	CbGeAlD
Pimozide—Pancytopenia—Etoposide—brain cancer	0.000684	0.00441	CcSEcCtD
Pimozide—CALM1—pituitary gland—brain cancer	0.000683	0.00348	CbGeAlD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000678	0.00438	CcSEcCtD
Pimozide—Eye disorder—Temozolomide—brain cancer	0.000673	0.00434	CcSEcCtD
Pimozide—Urticaria—Procarbazine—brain cancer	0.000672	0.00434	CcSEcCtD
Pimozide—Cardiac disorder—Temozolomide—brain cancer	0.000668	0.00431	CcSEcCtD
Pimozide—CHRM2—endocrine gland—brain cancer	0.000667	0.0034	CbGeAlD
Pimozide—CALM2—medulla oblongata—brain cancer	0.000662	0.00338	CbGeAlD
Pimozide—OPRM1—central nervous system—brain cancer	0.00066	0.00337	CbGeAlD
Pimozide—CALM1—medulla oblongata—brain cancer	0.000659	0.00336	CbGeAlD
Pimozide—CHRM2—head—brain cancer	0.000658	0.00336	CbGeAlD
Pimozide—Mental disorder—Carmustine—brain cancer	0.000653	0.00421	CcSEcCtD
Pimozide—Nervous system disorder—Hydroxyurea—brain cancer	0.000642	0.00415	CcSEcCtD
Pimozide—Skin disorder—Hydroxyurea—brain cancer	0.000636	0.00411	CcSEcCtD
Pimozide—Mental disorder—Temozolomide—brain cancer	0.000631	0.00407	CcSEcCtD
Pimozide—DRD2—pituitary gland—brain cancer	0.000631	0.00322	CbGeAlD
Pimozide—Anorexia—Hydroxyurea—brain cancer	0.000624	0.00403	CcSEcCtD
Pimozide—KCNH2—pituitary gland—brain cancer	0.000622	0.00317	CbGeAlD
Pimozide—HTR1A—midbrain—brain cancer	0.000616	0.00314	CbGeAlD
Pimozide—HRH1—telencephalon—brain cancer	0.000612	0.00312	CbGeAlD
Pimozide—Vision blurred—Carmustine—brain cancer	0.000611	0.00395	CcSEcCtD
Pimozide—Tremor—Carmustine—brain cancer	0.000608	0.00392	CcSEcCtD
Pimozide—Asthenia—Procarbazine—brain cancer	0.000607	0.00392	CcSEcCtD
Pimozide—CALM2—midbrain—brain cancer	0.000605	0.00309	CbGeAlD
Pimozide—CALM1—midbrain—brain cancer	0.000602	0.00307	CbGeAlD
Pimozide—HTR1A—spinal cord—brain cancer	0.000601	0.00306	CbGeAlD
Pimozide—CHRM2—central nervous system—brain cancer	0.000601	0.00306	CbGeAlD
Pimozide—KCNH2—medulla oblongata—brain cancer	0.0006	0.00306	CbGeAlD
Pimozide—Anaemia—Carmustine—brain cancer	0.0006	0.00387	CcSEcCtD
Pimozide—Agranulocytosis—Etoposide—brain cancer	0.000599	0.00387	CcSEcCtD
Pimozide—Pruritus—Procarbazine—brain cancer	0.000599	0.00386	CcSEcCtD
Pimozide—CALM3—cerebellum—brain cancer	0.000596	0.00304	CbGeAlD
Pimozide—Agitation—Carmustine—brain cancer	0.000596	0.00385	CcSEcCtD
Pimozide—Vision blurred—Temozolomide—brain cancer	0.000591	0.00381	CcSEcCtD
Pimozide—CALM2—spinal cord—brain cancer	0.00059	0.00301	CbGeAlD
Pimozide—CYP2E1—telencephalon—brain cancer	0.000588	0.003	CbGeAlD
Pimozide—CALM1—spinal cord—brain cancer	0.000588	0.003	CbGeAlD
Pimozide—Tremor—Temozolomide—brain cancer	0.000587	0.00379	CcSEcCtD
Pimozide—Somnolence—Hydroxyurea—brain cancer	0.000582	0.00376	CcSEcCtD
Pimozide—Leukopenia—Carmustine—brain cancer	0.000581	0.00375	CcSEcCtD
Pimozide—Anaemia—Temozolomide—brain cancer	0.000579	0.00374	CcSEcCtD
Pimozide—Diarrhoea—Procarbazine—brain cancer	0.000579	0.00374	CcSEcCtD
Pimozide—Agitation—Temozolomide—brain cancer	0.000576	0.00372	CcSEcCtD
Pimozide—HTR2A—brainstem—brain cancer	0.000576	0.00294	CbGeAlD
Pimozide—Decreased appetite—Hydroxyurea—brain cancer	0.000569	0.00367	CcSEcCtD
Pimozide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000565	0.00365	CcSEcCtD
Pimozide—Convulsion—Carmustine—brain cancer	0.000562	0.00363	CcSEcCtD
Pimozide—Leukopenia—Temozolomide—brain cancer	0.000561	0.00362	CcSEcCtD
Pimozide—Hypertension—Carmustine—brain cancer	0.00056	0.00362	CcSEcCtD
Pimozide—Constipation—Hydroxyurea—brain cancer	0.00056	0.00361	CcSEcCtD
Pimozide—Dizziness—Procarbazine—brain cancer	0.00056	0.00361	CcSEcCtD
Pimozide—DRD2—midbrain—brain cancer	0.000556	0.00284	CbGeAlD
Pimozide—Palpitations—Temozolomide—brain cancer	0.000554	0.00358	CcSEcCtD
Pimozide—Myalgia—Carmustine—brain cancer	0.000552	0.00356	CcSEcCtD
Pimozide—Chest pain—Carmustine—brain cancer	0.000552	0.00356	CcSEcCtD
Pimozide—KCNH2—midbrain—brain cancer	0.000548	0.0028	CbGeAlD
Pimozide—Convulsion—Temozolomide—brain cancer	0.000543	0.00351	CcSEcCtD
Pimozide—Hypertension—Temozolomide—brain cancer	0.000541	0.00349	CcSEcCtD
Pimozide—HTR1A—endocrine gland—brain cancer	0.000541	0.00276	CbGeAlD
Pimozide—Eye disorder—Etoposide—brain cancer	0.000538	0.00348	CcSEcCtD
Pimozide—Vomiting—Procarbazine—brain cancer	0.000538	0.00347	CcSEcCtD
Pimozide—KCNH2—spinal cord—brain cancer	0.000535	0.00273	CbGeAlD
Pimozide—Cardiac disorder—Etoposide—brain cancer	0.000535	0.00345	CcSEcCtD
Pimozide—HTR1A—head—brain cancer	0.000534	0.00272	CbGeAlD
Pimozide—Myalgia—Temozolomide—brain cancer	0.000534	0.00344	CcSEcCtD
Pimozide—Rash—Procarbazine—brain cancer	0.000534	0.00344	CcSEcCtD
Pimozide—Dermatitis—Procarbazine—brain cancer	0.000533	0.00344	CcSEcCtD
Pimozide—CALM2—endocrine gland—brain cancer	0.000532	0.00271	CbGeAlD
Pimozide—Headache—Procarbazine—brain cancer	0.00053	0.00342	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00053	0.00342	CcSEcCtD
Pimozide—CALM1—endocrine gland—brain cancer	0.000529	0.0027	CbGeAlD
Pimozide—CALM2—head—brain cancer	0.000525	0.00268	CbGeAlD
Pimozide—CYP2D6—brainstem—brain cancer	0.000525	0.00268	CbGeAlD
Pimozide—OPRM1—brain—brain cancer	0.000524	0.00267	CbGeAlD
Pimozide—CALM1—head—brain cancer	0.000522	0.00266	CbGeAlD
Pimozide—Dry mouth—Temozolomide—brain cancer	0.000522	0.00337	CcSEcCtD
Pimozide—Tachycardia—Carmustine—brain cancer	0.000517	0.00334	CcSEcCtD
Pimozide—HTR2A—telencephalon—brain cancer	0.000511	0.00261	CbGeAlD
Pimozide—CYP2C19—endocrine gland—brain cancer	0.000505	0.00257	CbGeAlD
Pimozide—Anorexia—Carmustine—brain cancer	0.000505	0.00326	CcSEcCtD
Pimozide—Nausea—Procarbazine—brain cancer	0.000503	0.00324	CcSEcCtD
Pimozide—Nervous system disorder—Temozolomide—brain cancer	0.000502	0.00324	CcSEcCtD
Pimozide—Skin disorder—Temozolomide—brain cancer	0.000497	0.00321	CcSEcCtD
Pimozide—Hypotension—Carmustine—brain cancer	0.000495	0.00319	CcSEcCtD
Pimozide—Hyperhidrosis—Temozolomide—brain cancer	0.000495	0.00319	CcSEcCtD
Pimozide—DRD2—endocrine gland—brain cancer	0.000489	0.00249	CbGeAlD
Pimozide—Anorexia—Temozolomide—brain cancer	0.000488	0.00315	CcSEcCtD
Pimozide—HTR1A—central nervous system—brain cancer	0.000487	0.00249	CbGeAlD
Pimozide—CALM3—brain—brain cancer	0.000484	0.00247	CbGeAlD
Pimozide—DRD2—head—brain cancer	0.000482	0.00246	CbGeAlD
Pimozide—Musculoskeletal discomfort—Carmustine—brain cancer	0.000482	0.00311	CcSEcCtD
Pimozide—Muscle spasms—Etoposide—brain cancer	0.000482	0.00311	CcSEcCtD
Pimozide—KCNH2—endocrine gland—brain cancer	0.000482	0.00246	CbGeAlD
Pimozide—CALM2—central nervous system—brain cancer	0.000479	0.00244	CbGeAlD
Pimozide—Insomnia—Carmustine—brain cancer	0.000479	0.00309	CcSEcCtD
Pimozide—CHRM2—brain—brain cancer	0.000477	0.00243	CbGeAlD
Pimozide—CALM1—central nervous system—brain cancer	0.000477	0.00243	CbGeAlD
Pimozide—HTR1A—cerebellum—brain cancer	0.000476	0.00243	CbGeAlD
Pimozide—KCNH2—head—brain cancer	0.000475	0.00242	CbGeAlD
Pimozide—Somnolence—Carmustine—brain cancer	0.000471	0.00304	CcSEcCtD
Pimozide—Asthenia—Hydroxyurea—brain cancer	0.00047	0.00303	CcSEcCtD
Pimozide—CALM2—cerebellum—brain cancer	0.000468	0.00239	CbGeAlD
Pimozide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000466	0.00301	CcSEcCtD
Pimozide—CALM1—cerebellum—brain cancer	0.000466	0.00238	CbGeAlD
Pimozide—CYP2D6—telencephalon—brain cancer	0.000466	0.00237	CbGeAlD
Pimozide—Anaemia—Etoposide—brain cancer	0.000464	0.00299	CcSEcCtD
Pimozide—Insomnia—Temozolomide—brain cancer	0.000463	0.00299	CcSEcCtD
Pimozide—CYP2E1—medulla oblongata—brain cancer	0.000462	0.00236	CbGeAlD
Pimozide—Decreased appetite—Carmustine—brain cancer	0.00046	0.00297	CcSEcCtD
Pimozide—Gastrointestinal disorder—Carmustine—brain cancer	0.000457	0.00295	CcSEcCtD
Pimozide—Somnolence—Temozolomide—brain cancer	0.000455	0.00294	CcSEcCtD
Pimozide—Constipation—Carmustine—brain cancer	0.000453	0.00292	CcSEcCtD
Pimozide—Leukopenia—Etoposide—brain cancer	0.000449	0.0029	CcSEcCtD
Pimozide—Diarrhoea—Hydroxyurea—brain cancer	0.000448	0.00289	CcSEcCtD
Pimozide—Decreased appetite—Temozolomide—brain cancer	0.000445	0.00287	CcSEcCtD
Pimozide—Gastrointestinal disorder—Temozolomide—brain cancer	0.000442	0.00285	CcSEcCtD
Pimozide—Loss of consciousness—Etoposide—brain cancer	0.000441	0.00285	CcSEcCtD
Pimozide—DRD2—central nervous system—brain cancer	0.00044	0.00225	CbGeAlD
Pimozide—Constipation—Temozolomide—brain cancer	0.000437	0.00282	CcSEcCtD
Pimozide—Convulsion—Etoposide—brain cancer	0.000435	0.00281	CcSEcCtD
Pimozide—KCNH2—central nervous system—brain cancer	0.000434	0.00221	CbGeAlD
Pimozide—Hypertension—Etoposide—brain cancer	0.000433	0.0028	CcSEcCtD
Pimozide—Dizziness—Hydroxyurea—brain cancer	0.000433	0.0028	CcSEcCtD
Pimozide—DRD2—cerebellum—brain cancer	0.00043	0.0022	CbGeAlD
Pimozide—Chest pain—Etoposide—brain cancer	0.000427	0.00276	CcSEcCtD
Pimozide—HTR2A—gonad—brain cancer	0.000427	0.00218	CbGeAlD
Pimozide—KCNH2—cerebellum—brain cancer	0.000424	0.00216	CbGeAlD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000424	0.00274	CcSEcCtD
Pimozide—Vomiting—Hydroxyurea—brain cancer	0.000416	0.00269	CcSEcCtD
Pimozide—HTR2A—pituitary gland—brain cancer	0.000416	0.00212	CbGeAlD
Pimozide—Rash—Hydroxyurea—brain cancer	0.000413	0.00267	CcSEcCtD
Pimozide—Dermatitis—Hydroxyurea—brain cancer	0.000413	0.00266	CcSEcCtD
Pimozide—CYP1A2—endocrine gland—brain cancer	0.000412	0.0021	CbGeAlD
Pimozide—CYP2E1—spinal cord—brain cancer	0.000412	0.0021	CbGeAlD
Pimozide—Headache—Hydroxyurea—brain cancer	0.00041	0.00265	CcSEcCtD
Pimozide—Urticaria—Temozolomide—brain cancer	0.000406	0.00262	CcSEcCtD
Pimozide—HTR2A—medulla oblongata—brain cancer	0.000402	0.00205	CbGeAlD
Pimozide—Tachycardia—Etoposide—brain cancer	0.0004	0.00258	CcSEcCtD
Pimozide—Skin disorder—Etoposide—brain cancer	0.000398	0.00257	CcSEcCtD
Pimozide—CYP3A5—endocrine gland—brain cancer	0.000398	0.00203	CbGeAlD
Pimozide—Hyperhidrosis—Etoposide—brain cancer	0.000396	0.00255	CcSEcCtD
Pimozide—Anorexia—Etoposide—brain cancer	0.00039	0.00252	CcSEcCtD
Pimozide—Nausea—Hydroxyurea—brain cancer	0.000389	0.00251	CcSEcCtD
Pimozide—HTR1A—brain—brain cancer	0.000387	0.00197	CbGeAlD
Pimozide—HRH1—endocrine gland—brain cancer	0.000386	0.00197	CbGeAlD
Pimozide—Hypotension—Etoposide—brain cancer	0.000383	0.00247	CcSEcCtD
Pimozide—HRH1—head—brain cancer	0.000381	0.00194	CbGeAlD
Pimozide—CALM2—brain—brain cancer	0.00038	0.00194	CbGeAlD
Pimozide—Asthenia—Carmustine—brain cancer	0.00038	0.00245	CcSEcCtD
Pimozide—CALM1—brain—brain cancer	0.000379	0.00193	CbGeAlD
Pimozide—CYP2E1—endocrine gland—brain cancer	0.000371	0.00189	CbGeAlD
Pimozide—Asthenia—Temozolomide—brain cancer	0.000367	0.00237	CcSEcCtD
Pimozide—HTR2A—midbrain—brain cancer	0.000367	0.00187	CbGeAlD
Pimozide—CYP2E1—head—brain cancer	0.000366	0.00187	CbGeAlD
Pimozide—Somnolence—Etoposide—brain cancer	0.000364	0.00235	CcSEcCtD
Pimozide—Diarrhoea—Carmustine—brain cancer	0.000362	0.00234	CcSEcCtD
Pimozide—Pruritus—Temozolomide—brain cancer	0.000362	0.00234	CcSEcCtD
Pimozide—HTR2A—spinal cord—brain cancer	0.000358	0.00183	CbGeAlD
Pimozide—Decreased appetite—Etoposide—brain cancer	0.000356	0.0023	CcSEcCtD
Pimozide—Gastrointestinal disorder—Etoposide—brain cancer	0.000353	0.00228	CcSEcCtD
Pimozide—Dizziness—Carmustine—brain cancer	0.00035	0.00226	CcSEcCtD
Pimozide—Constipation—Etoposide—brain cancer	0.00035	0.00226	CcSEcCtD
Pimozide—Diarrhoea—Temozolomide—brain cancer	0.00035	0.00226	CcSEcCtD
Pimozide—DRD2—brain—brain cancer	0.00035	0.00178	CbGeAlD
Pimozide—HRH1—central nervous system—brain cancer	0.000348	0.00177	CbGeAlD
Pimozide—KCNH2—brain—brain cancer	0.000344	0.00176	CbGeAlD
Pimozide—Dizziness—Temozolomide—brain cancer	0.000338	0.00218	CcSEcCtD
Pimozide—Vomiting—Carmustine—brain cancer	0.000337	0.00217	CcSEcCtD
Pimozide—ABCB1—telencephalon—brain cancer	0.000335	0.00171	CbGeAlD
Pimozide—CYP2E1—central nervous system—brain cancer	0.000334	0.0017	CbGeAlD
Pimozide—Rash—Carmustine—brain cancer	0.000334	0.00215	CcSEcCtD
Pimozide—Dermatitis—Carmustine—brain cancer	0.000333	0.00215	CcSEcCtD
Pimozide—Headache—Carmustine—brain cancer	0.000332	0.00214	CcSEcCtD
Pimozide—CYP2E1—cerebellum—brain cancer	0.000327	0.00167	CbGeAlD
Pimozide—Vomiting—Temozolomide—brain cancer	0.000325	0.0021	CcSEcCtD
Pimozide—Urticaria—Etoposide—brain cancer	0.000325	0.0021	CcSEcCtD
Pimozide—Rash—Temozolomide—brain cancer	0.000323	0.00208	CcSEcCtD
Pimozide—HTR2A—endocrine gland—brain cancer	0.000322	0.00164	CbGeAlD
Pimozide—Dermatitis—Temozolomide—brain cancer	0.000322	0.00208	CcSEcCtD
Pimozide—Headache—Temozolomide—brain cancer	0.00032	0.00207	CcSEcCtD
Pimozide—HTR2A—head—brain cancer	0.000318	0.00162	CbGeAlD
Pimozide—Nausea—Carmustine—brain cancer	0.000314	0.00203	CcSEcCtD
Pimozide—Nausea—Temozolomide—brain cancer	0.000304	0.00196	CcSEcCtD
Pimozide—CYP3A4—endocrine gland—brain cancer	0.000298	0.00152	CbGeAlD
Pimozide—Asthenia—Etoposide—brain cancer	0.000294	0.0019	CcSEcCtD
Pimozide—CYP2D6—endocrine gland—brain cancer	0.000294	0.0015	CbGeAlD
Pimozide—HTR2A—central nervous system—brain cancer	0.00029	0.00148	CbGeAlD
Pimozide—CYP2D6—head—brain cancer	0.00029	0.00148	CbGeAlD
Pimozide—Pruritus—Etoposide—brain cancer	0.00029	0.00187	CcSEcCtD
Pimozide—HTR2A—cerebellum—brain cancer	0.000284	0.00145	CbGeAlD
Pimozide—Flunarizine—CYP2C9—brain cancer	0.000282	1	CrCbGaD
Pimozide—Diarrhoea—Etoposide—brain cancer	0.00028	0.00181	CcSEcCtD
Pimozide—ABCB1—gonad—brain cancer	0.000279	0.00143	CbGeAlD
Pimozide—HRH1—brain—brain cancer	0.000276	0.00141	CbGeAlD
Pimozide—ABCB1—pituitary gland—brain cancer	0.000273	0.00139	CbGeAlD
Pimozide—Dizziness—Etoposide—brain cancer	0.000271	0.00175	CcSEcCtD
Pimozide—CYP3A4—central nervous system—brain cancer	0.000269	0.00137	CbGeAlD
Pimozide—CYP2E1—brain—brain cancer	0.000265	0.00135	CbGeAlD
Pimozide—CYP2D6—central nervous system—brain cancer	0.000265	0.00135	CbGeAlD
Pimozide—ABCB1—medulla oblongata—brain cancer	0.000263	0.00134	CbGeAlD
Pimozide—Vomiting—Etoposide—brain cancer	0.00026	0.00168	CcSEcCtD
Pimozide—CYP2D6—cerebellum—brain cancer	0.000259	0.00132	CbGeAlD
Pimozide—Rash—Etoposide—brain cancer	0.000258	0.00167	CcSEcCtD
Pimozide—Dermatitis—Etoposide—brain cancer	0.000258	0.00166	CcSEcCtD
Pimozide—Headache—Etoposide—brain cancer	0.000256	0.00166	CcSEcCtD
Pimozide—Nausea—Etoposide—brain cancer	0.000243	0.00157	CcSEcCtD
Pimozide—ABCB1—midbrain—brain cancer	0.00024	0.00123	CbGeAlD
Pimozide—ABCB1—spinal cord—brain cancer	0.000235	0.0012	CbGeAlD
Pimozide—HTR2A—brain—brain cancer	0.000231	0.00118	CbGeAlD
Pimozide—ABCB1—endocrine gland—brain cancer	0.000211	0.00108	CbGeAlD
Pimozide—CYP2D6—brain—brain cancer	0.00021	0.00107	CbGeAlD
Pimozide—ABCB1—head—brain cancer	0.000209	0.00106	CbGeAlD
Pimozide—ABCB1—central nervous system—brain cancer	0.00019	0.000971	CbGeAlD
Pimozide—ABCB1—cerebellum—brain cancer	0.000186	0.000949	CbGeAlD
Pimozide—ABCB1—brain—brain cancer	0.000151	0.000771	CbGeAlD
Pimozide—DRD2—GPCR downstream signaling—IL2—brain cancer	1.56e-05	0.000108	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—HES1—brain cancer	1.55e-05	0.000108	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—PIK3CG—brain cancer	1.55e-05	0.000108	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—APC—brain cancer	1.55e-05	0.000108	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NOTCH2—brain cancer	1.55e-05	0.000108	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NOTCH2—brain cancer	1.55e-05	0.000108	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—IL2—brain cancer	1.53e-05	0.000107	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PDGFRA—brain cancer	1.53e-05	0.000106	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IRS2—brain cancer	1.53e-05	0.000106	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ENO2—brain cancer	1.53e-05	0.000106	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—IL2—brain cancer	1.53e-05	0.000106	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VAV1—brain cancer	1.53e-05	0.000106	CbGpPWpGaD
Pimozide—CALM2—Disease—IRS2—brain cancer	1.52e-05	0.000105	CbGpPWpGaD
Pimozide—CALM1—Disease—IRS2—brain cancer	1.52e-05	0.000105	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PDGFRA—brain cancer	1.51e-05	0.000105	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—IL2—brain cancer	1.5e-05	0.000105	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PDGFRA—brain cancer	1.5e-05	0.000105	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—IDH1—brain cancer	1.49e-05	0.000104	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—SPP1—brain cancer	1.49e-05	0.000103	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PDGFRA—brain cancer	1.48e-05	0.000103	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VAV1—brain cancer	1.48e-05	0.000103	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VAV1—brain cancer	1.48e-05	0.000103	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—SPP1—brain cancer	1.46e-05	0.000102	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—SPP1—brain cancer	1.46e-05	0.000101	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—RELA—brain cancer	1.45e-05	0.000101	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—ERBB2—brain cancer	1.44e-05	0.0001	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—SPP1—brain cancer	1.43e-05	9.98e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—RELA—brain cancer	1.43e-05	9.92e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—EGFR—brain cancer	1.43e-05	9.92e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—ERBB2—brain cancer	1.42e-05	9.86e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—IL2—brain cancer	1.41e-05	9.83e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—EGFR—brain cancer	1.41e-05	9.83e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—IL2—brain cancer	1.39e-05	9.67e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—IL2—brain cancer	1.39e-05	9.65e-05	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—EGFR—brain cancer	1.38e-05	9.64e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—APC—brain cancer	1.38e-05	9.63e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—IL2—brain cancer	1.37e-05	9.5e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—APC—brain cancer	1.35e-05	9.4e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—PIK3CG—brain cancer	1.35e-05	9.4e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IRS2—brain cancer	1.34e-05	9.35e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—EGFR—brain cancer	1.34e-05	9.32e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—EGFR—brain cancer	1.34e-05	9.32e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—APC—brain cancer	1.34e-05	9.31e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—APC—brain cancer	1.34e-05	9.31e-05	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—EGFR—brain cancer	1.33e-05	9.25e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IRS2—brain cancer	1.32e-05	9.2e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IRS2—brain cancer	1.32e-05	9.18e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—HES1—brain cancer	1.31e-05	9.13e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL2—brain cancer	1.3e-05	9.07e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IRS2—brain cancer	1.3e-05	9.03e-05	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—TP53—brain cancer	1.29e-05	8.99e-05	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—EGFR—brain cancer	1.29e-05	8.95e-05	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—EGFR—brain cancer	1.29e-05	8.95e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL2—brain cancer	1.28e-05	8.94e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—CCND1—brain cancer	1.27e-05	8.84e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HES1—brain cancer	1.27e-05	8.83e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HES1—brain cancer	1.27e-05	8.83e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—CTNNB1—brain cancer	1.26e-05	8.75e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—CCND1—brain cancer	1.25e-05	8.71e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PDGFRA—brain cancer	1.25e-05	8.69e-05	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—TP53—brain cancer	1.25e-05	8.69e-05	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—TP53—brain cancer	1.25e-05	8.69e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—CTNNB1—brain cancer	1.24e-05	8.63e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.23e-05	8.56e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—RELA—brain cancer	1.22e-05	8.51e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—ERBB2—brain cancer	1.22e-05	8.46e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SPP1—brain cancer	1.21e-05	8.44e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—RELA—brain cancer	1.21e-05	8.43e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PDGFRA—brain cancer	1.21e-05	8.41e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PDGFRA—brain cancer	1.21e-05	8.41e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—ERBB2—brain cancer	1.2e-05	8.38e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—APC—brain cancer	1.19e-05	8.25e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.19e-05	8.25e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ENO2—brain cancer	1.18e-05	8.21e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SPP1—brain cancer	1.17e-05	8.16e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SPP1—brain cancer	1.17e-05	8.16e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—RELA—brain cancer	1.17e-05	8.15e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.17e-05	8.12e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—APC—brain cancer	1.17e-05	8.12e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PIK3CG—brain cancer	1.17e-05	8.11e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—APC—brain cancer	1.16e-05	8.1e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PIK3CG—brain cancer	1.16e-05	8.1e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PIK3CG—brain cancer	1.16e-05	8.1e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—ERBB2—brain cancer	1.16e-05	8.1e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PIK3CG—brain cancer	1.16e-05	8.06e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL2—brain cancer	1.15e-05	8.03e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PIK3CG—brain cancer	1.15e-05	7.97e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—APC—brain cancer	1.15e-05	7.97e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—RELA—brain cancer	1.13e-05	7.88e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—RELA—brain cancer	1.13e-05	7.88e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—ERBB2—brain cancer	1.13e-05	7.83e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—ERBB2—brain cancer	1.13e-05	7.83e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PIK3CG—brain cancer	1.12e-05	7.8e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PIK3CG—brain cancer	1.12e-05	7.8e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL2—brain cancer	1.12e-05	7.77e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL2—brain cancer	1.12e-05	7.77e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—VEGFA—brain cancer	1.11e-05	7.71e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL2—brain cancer	1.1e-05	7.66e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IRS2—brain cancer	1.1e-05	7.63e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—STAT3—brain cancer	1.1e-05	7.63e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—VEGFA—brain cancer	1.09e-05	7.6e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL2—brain cancer	1.09e-05	7.59e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—STAT3—brain cancer	1.08e-05	7.52e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—EGFR—brain cancer	1.08e-05	7.52e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—ERBB2—brain cancer	1.07e-05	7.48e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CCND1—brain cancer	1.07e-05	7.47e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CCND1—brain cancer	1.06e-05	7.4e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—EGFR—brain cancer	1.06e-05	7.4e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CTNNB1—brain cancer	1.06e-05	7.4e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IRS2—brain cancer	1.06e-05	7.38e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IRS2—brain cancer	1.06e-05	7.38e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—EGFR—brain cancer	1.06e-05	7.38e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—RELA—brain cancer	1.06e-05	7.35e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL2—brain cancer	1.05e-05	7.34e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CTNNB1—brain cancer	1.05e-05	7.33e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—ERBB2—brain cancer	1.05e-05	7.3e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—EGFR—brain cancer	1.04e-05	7.26e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—ERBB2—brain cancer	1.04e-05	7.23e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—ERBB2—brain cancer	1.04e-05	7.23e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL2—brain cancer	1.02e-05	7.1e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL2—brain cancer	1.02e-05	7.1e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—MYC—brain cancer	1.02e-05	7.09e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—CTNNB1—brain cancer	1.02e-05	7.08e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—MYC—brain cancer	1e-05	6.99e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—EGFR—brain cancer	9.97e-06	6.94e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—CTNNB1—brain cancer	9.85e-06	6.85e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—CTNNB1—brain cancer	9.85e-06	6.85e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—EGFR—brain cancer	9.82e-06	6.83e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—APC—brain cancer	9.69e-06	6.74e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CG—brain cancer	9.69e-06	6.74e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL2—brain cancer	9.51e-06	6.62e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—CTNNB1—brain cancer	9.4e-06	6.54e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—APC—brain cancer	9.37e-06	6.52e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CG—brain cancer	9.37e-06	6.52e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CG—brain cancer	9.37e-06	6.52e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—APC—brain cancer	9.37e-06	6.52e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—VEGFA—brain cancer	9.36e-06	6.51e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—VEGFA—brain cancer	9.27e-06	6.45e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—RELA—brain cancer	9.27e-06	6.45e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—STAT3—brain cancer	9.27e-06	6.45e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CCND1—brain cancer	9.27e-06	6.45e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—ERBB2—brain cancer	9.21e-06	6.41e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—STAT3—brain cancer	9.18e-06	6.39e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CTNNB1—brain cancer	9.18e-06	6.39e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—RELA—brain cancer	9.12e-06	6.35e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—RELA—brain cancer	9.1e-06	6.33e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—CTNNB1—brain cancer	9.09e-06	6.33e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—CTNNB1—brain cancer	9.09e-06	6.33e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—ERBB2—brain cancer	9.06e-06	6.31e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—ERBB2—brain cancer	9.04e-06	6.29e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CG—brain cancer	9e-06	6.26e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—RELA—brain cancer	8.96e-06	6.23e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—ERBB2—brain cancer	8.9e-06	6.19e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—STAT3—brain cancer	8.88e-06	6.17e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—EGFR—brain cancer	8.83e-06	6.14e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CG—brain cancer	8.78e-06	6.11e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MYC—brain cancer	8.61e-06	5.99e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—STAT3—brain cancer	8.59e-06	5.97e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—STAT3—brain cancer	8.59e-06	5.97e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—EGFR—brain cancer	8.54e-06	5.94e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—EGFR—brain cancer	8.54e-06	5.94e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MYC—brain cancer	8.53e-06	5.94e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—EGFR—brain cancer	8.43e-06	5.86e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TP53—brain cancer	8.37e-06	5.82e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL2—brain cancer	8.35e-06	5.81e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—EGFR—brain cancer	8.34e-06	5.81e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CG—brain cancer	8.28e-06	5.76e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TP53—brain cancer	8.25e-06	5.74e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL2—brain cancer	8.21e-06	5.72e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL2—brain cancer	8.2e-06	5.7e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—STAT3—brain cancer	8.19e-06	5.7e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CCND1—brain cancer	8.14e-06	5.66e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—VEGFA—brain cancer	8.08e-06	5.62e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—EGFR—brain cancer	8.07e-06	5.61e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL2—brain cancer	8.07e-06	5.61e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CTNNB1—brain cancer	8.06e-06	5.61e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CCND1—brain cancer	8.01e-06	5.57e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—STAT3—brain cancer	8e-06	5.57e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CCND1—brain cancer	7.99e-06	5.56e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CTNNB1—brain cancer	7.93e-06	5.52e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—STAT3—brain cancer	7.93e-06	5.51e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—STAT3—brain cancer	7.93e-06	5.51e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CTNNB1—brain cancer	7.91e-06	5.51e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CCND1—brain cancer	7.86e-06	5.47e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—EGFR—brain cancer	7.8e-06	5.43e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—EGFR—brain cancer	7.8e-06	5.43e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CTNNB1—brain cancer	7.79e-06	5.42e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MYC—brain cancer	7.61e-06	5.3e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—RELA—brain cancer	7.57e-06	5.27e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—ERBB2—brain cancer	7.52e-06	5.23e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—EGFR—brain cancer	7.45e-06	5.18e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MYC—brain cancer	7.43e-06	5.17e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MYC—brain cancer	7.37e-06	5.12e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MYC—brain cancer	7.37e-06	5.12e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—RELA—brain cancer	7.32e-06	5.1e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—RELA—brain cancer	7.32e-06	5.1e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ERBB2—brain cancer	7.28e-06	5.06e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ERBB2—brain cancer	7.28e-06	5.06e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—EGFR—brain cancer	7.27e-06	5.06e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—EGFR—brain cancer	7.2e-06	5.01e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—EGFR—brain cancer	7.2e-06	5.01e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—brain cancer	7.1e-06	4.94e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—brain cancer	7.07e-06	4.92e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—STAT3—brain cancer	7.03e-06	4.89e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CG—brain cancer	7.01e-06	4.88e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—brain cancer	7.01e-06	4.87e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—brain cancer	6.98e-06	4.86e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—brain cancer	6.97e-06	4.85e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—STAT3—brain cancer	6.91e-06	4.81e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—STAT3—brain cancer	6.9e-06	4.8e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—brain cancer	6.85e-06	4.77e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2—brain cancer	6.82e-06	4.74e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—STAT3—brain cancer	6.79e-06	4.72e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCND1—brain cancer	6.65e-06	4.62e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL2—brain cancer	6.6e-06	4.59e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2—brain cancer	6.6e-06	4.59e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CTNNB1—brain cancer	6.58e-06	4.58e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MYC—brain cancer	6.53e-06	4.54e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCND1—brain cancer	6.43e-06	4.47e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCND1—brain cancer	6.43e-06	4.47e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MYC—brain cancer	6.42e-06	4.47e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MYC—brain cancer	6.41e-06	4.46e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—EGFR—brain cancer	6.38e-06	4.44e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CTNNB1—brain cancer	6.37e-06	4.43e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CTNNB1—brain cancer	6.37e-06	4.43e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MYC—brain cancer	6.31e-06	4.39e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EGFR—brain cancer	6.28e-06	4.37e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EGFR—brain cancer	6.27e-06	4.36e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EGFR—brain cancer	6.17e-06	4.29e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—brain cancer	6.11e-06	4.25e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—brain cancer	5.8e-06	4.03e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—STAT3—brain cancer	5.74e-06	3.99e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—brain cancer	5.61e-06	3.9e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—brain cancer	5.61e-06	3.9e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—STAT3—brain cancer	5.55e-06	3.86e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—STAT3—brain cancer	5.55e-06	3.86e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CG—brain cancer	5.41e-06	3.76e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—brain cancer	5.36e-06	3.73e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MYC—brain cancer	5.33e-06	3.71e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—brain cancer	5.27e-06	3.67e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—brain cancer	5.26e-06	3.66e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EGFR—brain cancer	5.22e-06	3.63e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—brain cancer	5.18e-06	3.6e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MYC—brain cancer	5.16e-06	3.59e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MYC—brain cancer	5.16e-06	3.59e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EGFR—brain cancer	5.04e-06	3.51e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EGFR—brain cancer	5.04e-06	3.51e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—brain cancer	4.38e-06	3.05e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—brain cancer	4.24e-06	2.95e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—brain cancer	4.24e-06	2.95e-05	CbGpPWpGaD
